Skip to main content
Top
Published in: Cellular Oncology 4/2023

22-02-2023 | Review

Altered iron metabolism as a target for ferroptosis induction in head and neck cancer

Authors: Jaewang Lee, Jong-Lyel Roh

Published in: Cellular Oncology | Issue 4/2023

Login to get access

Abstract

Iron is a mineral micronutrient essential for survival and vital functions in many biological processes in living organisms. Iron plays a crucial role as a cofactor of iron-sulfur clusters in energy metabolism and biosynthesis by binding with enzymes and transferring electrons to targets. Iron can also impair cellular functions by damaging organelles and nucleic acids by producing free radicals from redox cycling. Iron-catalyzed reaction products can induce active-site mutations in tumorigenesis and cancer progression. However, the boosted pro-oxidant iron form may contribute to cytotoxicity by increasing soluble radicals and highly reactive oxygen species via the Fenton reaction. An increased redox-active labile iron pool is required for tumor growth and metastasis, but the increased cytotoxic lipid radicals also lead to regulated cell death, such as ferroptosis. Therefore, this may be a major target for selectively killing cancer cells. This review intends to understand altered iron metabolism in cancers and discuss iron-related molecular regulators highly associated with iron-induced cytotoxic radical production and ferroptosis induction, focusing on head and neck cancer.
Literature
8.
15.
go back to reference J.T. Busher, in Clinical Methods: The History, Physical, and Laboratory Examinations, ed. by H.K. Walker, W.D. Hall and J.W. Hurst (Butterworths 1990), pp. 497–499 J.T. Busher, in Clinical Methods: The History, Physical, and Laboratory Examinations, ed. by H.K. Walker, W.D. Hall and J.W. Hurst (Butterworths 1990), pp. 497–499
61.
go back to reference S. Doll, F.P. Freitas, R. Shah, M. Aldrovandi, M.C. da Silva, I. Ingold, A. Goya Grocin, T.N. Xavier da Silva, E. Panzilius, C.H. Scheel, A. Mourão, K. Buday, M. Sato, J. Wanninger, T. Vignane, V. Mohana, M. Rehberg, A. Flatley, A. Schepers, A. Kurz, D. White, M. Sauer, M. Sattler, E.W. Tate, W. Schmitz, A. Schulze, V. O’Donnell, B. Proneth, G.M. Popowicz, D.A. Pratt, J.P.F. Angeli, M. Conrad, Nature 575, 693–698 (2019). https://doi.org/10.1038/s41586-019-1707-0 S. Doll, F.P. Freitas, R. Shah, M. Aldrovandi, M.C. da Silva, I. Ingold, A. Goya Grocin, T.N. Xavier da Silva, E. Panzilius, C.H. Scheel, A. Mourão, K. Buday, M. Sato, J. Wanninger, T. Vignane, V. Mohana, M. Rehberg, A. Flatley, A. Schepers, A. Kurz, D. White, M. Sauer, M. Sattler, E.W. Tate, W. Schmitz, A. Schulze, V. O’Donnell, B. Proneth, G.M. Popowicz, D.A. Pratt, J.P.F. Angeli, M. Conrad, Nature 575, 693–698 (2019). https://​doi.​org/​10.​1038/​s41586-019-1707-0
Metadata
Title
Altered iron metabolism as a target for ferroptosis induction in head and neck cancer
Authors
Jaewang Lee
Jong-Lyel Roh
Publication date
22-02-2023
Publisher
Springer Netherlands
Published in
Cellular Oncology / Issue 4/2023
Print ISSN: 2211-3428
Electronic ISSN: 2211-3436
DOI
https://doi.org/10.1007/s13402-023-00784-y

Other articles of this Issue 4/2023

Cellular Oncology 4/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine